✦ LIBER ✦

Impact of activating fibroblast growth factor receptor 3 mutation in endochondral ossification

✍ Scribed by E. Mugniery; R. Dacquin; C. Marty; C. Benoist-Lasselin; A. Munnich; M.-C. de Vernejoul; P. Jurdic; V. Geoffroy; L. Legeai-Mallet

Book ID: 116324208
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 110 KB
Volume: 48
Category: Article
ISSN: 8756-3282
DOI: 10.1016/j.bone.2011.03.059

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Activation of Transforming Growth Factor

Activation of Transforming Growth Factor β in Chondrocytes Undergoing Endochondral Ossification

✍ Marina D'Angelo; David P. Sarment; Paul C. Billings; Maurizio Pacifici 📂 Article 📅 2001 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 683 KB

Asn540Lys mutation in fibroblast growth

Asn540Lys mutation in fibroblast growth factor receptor 3 and phenotype in hypochondroplasia

✍ G Grigelioniené; O Eklöf; E Laurencikas; B Ollars; NT Hertel; JP Dumanski; L Hag 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 487 KB

Prevalence of Pro250Arg mutation of fibr

Prevalence of Pro250Arg mutation of fibroblast growth factor receptor 3 in coronal craniosynostosis

✍ DM Moloney; SA Wall; GJ Ashworth; M Oldridge; IA Glass; CA Francomano; M Muenke; 📂 Article 📅 1997 🏛 The Lancet 🌐 English ⚖ 93 KB

Frequency of fibroblast growth factor re

Frequency of fibroblast growth factor receptor 3 mutations in sporadic tumours

✍ Sibley, Kathryn; Stern, Peter; Knowles, Margaret A 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 156 KB

Analysis of fibroblast growth factor rec

Analysis of fibroblast growth factor receptor 3 G697C mutation in oral squamous cell carcinomas

✍ Johannes Aubertin; Sophie Tourpin; François Janot; Jean-Charles Ahomadegbe; Fran 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 154 KB

Zhang et al. recently reported an activating mutation of the receptor tyrosine kinase fibroblast growth factor receptor 3 in 62% of 71 oral squamous cell carcinomas (OSCC). 1 More than 300,000 new cases of OSCC are diagnosed annually, worldwide. This aggressive epithelial cancer is associated with s

A novel missense mutation Ile538Val in t

A novel missense mutation Ile538Val in the fibroblast growth factor receptor 3 in hypochondroplasia

✍ G Grigelioniené; L Hagenäs; O Eklöf; L Neumeyer; PE Haereid; M Anvret 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 2 views

Hypochondroplasia and achondroplasia are skeletal dysplasias, characterised by autosomal dominant inheritance and disproportionate short stature, which occurs mainly due to growth failure of the extremities. Both dysplasias have been mapped to fibroblast growth factor receptor 3 (FGFR3) gene. For hy